Differential presentation of glutamic acid decarboxylase 65 (GAD65) T cell epitopes among HLA-DRB1*0401-positive individuals

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1674-1681

  Reijonen, Helena ^a   Elliott, John F ^b   Van Endert, Peter ^c   Nepom, Gerald ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLUTAMATE DECARBOXYLASE; HLA DR ANTIGEN; HUMAN SERUM ALBUMIN; LEUPEPTIN; PEPSTATIN;

ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; HLA SYSTEM; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOGENICITY; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELL LINEAGE; EPITOPES, T-LYMPHOCYTE; GLUTAMATE DECARBOXYLASE; HLA-DR ANTIGENS; HUMANS; LEUPEPTINS; LYMPHOCYTE ACTIVATION; PEPSTATINS; PROTEASE INHIBITORS; TRANSFECTION;

EID: 0033179486     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Atkinson, M. A., D. L. Kaufman, L. Campbell, K. A. Gibbs, S. C. Shah, D.-F. Bu, M. G. Erlander, A. J. Tobin, and N. K. Maclaren. 1992. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339:458.
2. Harrison, L. C., M. C. Honeyman, H. J. DeAizpurua, R. S. Schmidli, P. G. Colman, B. D. Tait, and D. S. Cram. 1993. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341:1365.
3. Atkinson, M. A., M. A. Bowman, L. Campbell, B. L. Darrow, D. L. Kaufman, and N. K. Maclaren. 1994. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J. Clin. Invest. 94:2125.
4. Lohmann, T., R. D. G. Leslie, M. Hawa, M. Geysen, S. Rodda, and M. Londei. 1994. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet 343:1607.
5. Geluk, A., K. E. van Meijgaarden, N. C. Schloot, J. Wouter Drijfhout, T. H. M. Ottenhoff, and B. O. Roep. 1998. HLA-DR binding analysis of peptides from islet antigens in IDDM. Diabetes 47:1594.
6. Endl, J., H. Otto, G. Jung, B. Dreisbusch, F. Donie, P. Stahl, R. Elbracht, G. Schmitz, E. Meinl, M. Hummel, et al. 1997. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 99:2405.
7. Bach, J. M., H. Otto, G. T. Nepom, G. Jung, H. Cohen, J. Timsit, C. Boitard, and P. M. van Endert. 1997. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease. J. Autoimmun. 10:375.
8. Lohmann, T., and M. Londei. 1996. T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J. Autoimmun. 9:385.
9. Vreugdenhil, G. R., A. Geluk, T. H. Ottenhoff, W. J. Melchers, B. O. Roep, and J. M. Galama. 1998. Molecular mimicry in diabetes mellitus: the homologous domain in coxsackie B virus protein 2C and islet autoantigen GAD65 is highly conserved in the coxsackie B-like enteroviruses and binds to the diabetes associated HLA-DR3 molecule. Diabetologia 41:40.
10. Patel, S. D., A. P. Cope, M. Congia, T. T. Chen, E. Kim, L. Fugger, D. Wherrett, and G. Sonderstrup-McDevitt. 1997. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR(α1*0101, βal*0401) transgenic mice. Proc. Natl. Acad. Sci. USA 94:8082.
11. Wicker, L. S., S.-L. Chen, G. T. Nepom, J. F. Elliott, D. C. Freed, A. Bansal, S. Zheng, A. Herman, Å. Lernmark, D. M. Zaller, et al. 1996. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB 1*0401. J. Clin. Invest. 98:2597.
12. Kaufman, D. L., M. Clare-Salzler, J. Tian, T. Forsthuber, G. S. P. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, and P. V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
13. Schneider, S. C., and E. E. Sercarz. 1997. Antigen processing differences among APC. Hum. Immunol. 54:148.
14. Panina-Bordignon, P., R. Lang, P. M. van Endert, E. Benazzi, A. M. Felix, R. M. Pastore, G. A. Spinas, and F. Sinigaglia. 1995. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J. Exp. Med. 181:1923.
15. Kwok, W. W., G. T. Nepom, and F. C. Raymond. 1995. HLA-DQ polymorphisms are highly selective for peptide binding interactions. J. Immunol. 155: 2468.
16. Hume, C. R., L. A. Shookster, N. Collins, R. O'Reilly, and J. S. Lee. 1989. Bare lymphocyte syndrome: altered HLA class II expression in B cell lines derived from two patients. Hum. Immunol. 25:1.
17. Kwok, W. W., D. Schwarz, B. S. Nepom, P. S. Thurtle, R. A. Hock, and G. T. Nepom. 1988. HLA-DQ molecules form α-β heterodimers of mixed allotype. J. Immunol. 141:3123.
18. Hao, W., T. Daniels, D. G. Pipeleers, A. Smismans, H. Reijonen, G. T. Nepom, and Å. Lernmark 1999. Radioimmunoassay for glutamic acid decarboxylase-65. Diabetes Technol. Ther. 1:13.
19. Adorini, L., and Z. A. Nagy. 1990. Peptide competition for antigen presentation. Immunol. Today 11:21.
20. Nepom, G. T. 1990. HLA and type I diabetes. Immunol. Today 11:314.
21. Tussey, L. G., S. Rowland-Jones, T. S. Zheng, M. J. Androlewicz, P. Cresswell, J. A. Frelinger, and A. J. McMichael. 1995. Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity 3:65.
22. Vidard, L., K. L. Rock, and B. Benacerraf. 1992. Heterogeneity in antigen processing by different types of antigen-presenting cells: effect of cell culture on antigen processing ability. J. Immunol. 149:1905.
23. Michaelsson, E., M. Holmdahl, A. Engstrom, H. Burkhardt, A. Scheynius, and R. Holmdahl. 1995. Macrophages, but not dendritic cells, present collagen to T cells. Eur. J. Immunol. 25:2234.
24. Liljedahl, M., T. Kuwana, W.-P. Fung-Leung, M. R. Jackson, P. A. Peterson, and L. Karlsson. 1997. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J. 15:4817.
25. Cella, M., A. Engering, V. Pinet, J. Pieters, and A. Lanzavecchia. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782.
26. Cella, M., F. Sallusto, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10.
27. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
28. Zhou, L. J., and T. F. Tedder. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154: 3821.
29. Griffin, J. P., R. Chu, and C. V. Harding. 1997. Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. J. Immunol. 158:1523.
30. Pinet, V., M. S. Malnati, and E. O. Long. 1994. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J. Immunol 152:4852.
31. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E. O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375: 603.
32. Zhong, G., P. Romagnoli, and R. N. Germain. 1997. Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein. J. Exp. Med. 185:429.
33. Walker, E., N. L. Warner, R. Chesnut, J. Kappler, and P. Marrack. 1982. Antigen-specific I region-restricted interactions in vitro between tumor cell lines and T cell hybridomas. J. Immunol. 128:2164.
34. Norcross, M. A., D. M. Bentley, D. H. Margulies, and R. N. Germain. 1984. Membrane Ia expression and antigen-presenting accessory cell function of L cells transfected with class II major histocompatibility complex genes. J. Exp. Med. 160:1316.
35. Malissen, B., M. P. Price, J. M. Goverman, M. McMillan, J. White, J. Kappler, P. Marrack, A. Pierres, M. Pierres, and L. Hood. 1984. Gene transfer of H-2 class II genes: antigen presentation by mouse fibroblast and hamster B-cell lines. Cell 36:319.
36. Shastri, N., B. Malissen, and L. Hood. 1985. Ia-transfected L-cell fibroblasts present a lysozyme peptide but not the native protein to lysozyme-specific T cells. Proc. Natl. Acad. Sci. USA 82:5885.
37. Michalek, M. T., B. Benacerraf, and K. L. Rock. 1989. Two genetically identical antigen-presenting cell clones display heterogeneity in antigen processing. Proc. Natl. Acad. Sci. USA 86:3316.
38. Vidard, L., K. L. Rock, and B. Benacerraf. 1991. The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors. J. Immunol. 147:1786.
39. + T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis. J. Immunol. 161:2120.
40. Moudgil, K. D., E. E. Sercarz, and I. S. Grewal. 1998. Modulation of the immunogenicity of antigenic determinants by their flanking residues. Immunol. Today 19:217.
41. Reyes, V. E., S. Lu, and R. E. Humphreys. 1991. Cathepsin B cleavage of Ii from class II MHC α-and β-chains. J. Immunol 146:3877.